
Nora Maureen Rooney
Examiner (ID: 2608, Phone: (571)272-9937 , Office: P/1644 )
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1641, 1644 |
| Total Applications | 916 |
| Issued Applications | 453 |
| Pending Applications | 111 |
| Abandoned Applications | 388 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8884126
[patent_doc_number] => 20130157310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-20
[patent_title] => 'Method for Production and Use of Mite Group 1 Proteins'
[patent_app_type] => utility
[patent_app_number] => 13/773395
[patent_app_country] => US
[patent_app_date] => 2013-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26212
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13773395
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/773395 | Method for Production and Use of Mite Group 1 Proteins | Feb 20, 2013 | Abandoned |
Array
(
[id] => 11635111
[patent_doc_number] => 09657070
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-23
[patent_title] => 'Recombinant allergen'
[patent_app_type] => utility
[patent_app_number] => 13/772046
[patent_app_country] => US
[patent_app_date] => 2013-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7166
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 209
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13772046
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/772046 | Recombinant allergen | Feb 19, 2013 | Issued |
Array
(
[id] => 9792255
[patent_doc_number] => 20150004189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'EPITOPES FROM ALLERGEN PROTEINS AND METHODS AND USES FOR IMMUNE RESPONSE MODULATION'
[patent_app_type] => utility
[patent_app_number] => 14/376757
[patent_app_country] => US
[patent_app_date] => 2013-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 69525
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14376757
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/376757 | EPITOPES FROM ALLERGEN PROTEINS AND METHODS AND USES FOR IMMUNE RESPONSE MODULATION | Feb 6, 2013 | Abandoned |
Array
(
[id] => 9812049
[patent_doc_number] => 20150023992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-22
[patent_title] => 'TIMOTHY GRASS ALLERGENS AND METHODS AND USES FOR IMMUNE RESPONSE MODULATION'
[patent_app_type] => utility
[patent_app_number] => 14/375980
[patent_app_country] => US
[patent_app_date] => 2013-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 69937
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14375980
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/375980 | Timothy grass allergens and methods and uses for immune response modulation | Feb 6, 2013 | Issued |
Array
(
[id] => 10142523
[patent_doc_number] => 09175326
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-03
[patent_title] => 'Transglycosylation activity of glycosynthase mutants of an endo-beta-N-acetylglucosaminidase (endo-D) from streptococcus pneumoniae'
[patent_app_type] => utility
[patent_app_number] => 13/759221
[patent_app_country] => US
[patent_app_date] => 2013-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12804
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13759221
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/759221 | Transglycosylation activity of glycosynthase mutants of an endo-beta-N-acetylglucosaminidase (endo-D) from streptococcus pneumoniae | Feb 4, 2013 | Issued |
Array
(
[id] => 10974276
[patent_doc_number] => 20140377311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'METHOD OF PREVENTING ALLERGIES'
[patent_app_type] => utility
[patent_app_number] => 14/373013
[patent_app_country] => US
[patent_app_date] => 2013-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6104
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14373013
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/373013 | METHOD OF PREVENTING ALLERGIES | Feb 3, 2013 | Abandoned |
Array
(
[id] => 9041112
[patent_doc_number] => 20130243750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'ANTI-IGE ANTIBODIES AND METHODS USING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/754572
[patent_app_country] => US
[patent_app_date] => 2013-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 49823
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13754572
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/754572 | ANTI-IGE ANTIBODIES AND METHODS USING SAME | Jan 29, 2013 | Abandoned |
Array
(
[id] => 9596715
[patent_doc_number] => 20140193395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-10
[patent_title] => 'SECRETORY IGA COMPOSITIONS, METHODS OF MAKING AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/734426
[patent_app_country] => US
[patent_app_date] => 2013-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6010
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13734426
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/734426 | Secretory IGA compositions, methods of making and methods of use thereof | Jan 3, 2013 | Issued |
Array
(
[id] => 9299640
[patent_doc_number] => 08647865
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-11
[patent_title] => 'Promiscuous PAP CD4 T cell epitopes'
[patent_app_type] => utility
[patent_app_number] => 13/734560
[patent_app_country] => US
[patent_app_date] => 2013-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 3
[patent_no_of_words] => 10872
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13734560
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/734560 | Promiscuous PAP CD4 T cell epitopes | Jan 3, 2013 | Issued |
Array
(
[id] => 8915970
[patent_doc_number] => 20130177594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-11
[patent_title] => 'PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/733253
[patent_app_country] => US
[patent_app_date] => 2013-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13786
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13733253
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/733253 | PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING THE SAME | Jan 2, 2013 | Abandoned |
Array
(
[id] => 9015587
[patent_doc_number] => 20130230551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-05
[patent_title] => 'Allergy Inhibitor Compositions And Kits And Methods Of Using The Same'
[patent_app_type] => utility
[patent_app_number] => 13/721449
[patent_app_country] => US
[patent_app_date] => 2012-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 20373
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13721449
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/721449 | Allergy inhibitor compositions and kits and methods of using the same | Dec 19, 2012 | Issued |
Array
(
[id] => 10057332
[patent_doc_number] => 09096677
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-04
[patent_title] => 'Humaneered anti-factor B antibody'
[patent_app_type] => utility
[patent_app_number] => 13/722071
[patent_app_country] => US
[patent_app_date] => 2012-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17340
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 252
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13722071
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/722071 | Humaneered anti-factor B antibody | Dec 19, 2012 | Issued |
Array
(
[id] => 8767082
[patent_doc_number] => 20130095119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-18
[patent_title] => 'COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING AN INFLAMMATION'
[patent_app_type] => utility
[patent_app_number] => 13/721309
[patent_app_country] => US
[patent_app_date] => 2012-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 26865
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13721309
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/721309 | Compositions and methods for diagnosing and treating an inflammation | Dec 19, 2012 | Issued |
Array
(
[id] => 11827597
[patent_doc_number] => 09724326
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-08
[patent_title] => 'Method of treating celiac disease'
[patent_app_type] => utility
[patent_app_number] => 14/367171
[patent_app_country] => US
[patent_app_date] => 2012-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4137
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14367171
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/367171 | Method of treating celiac disease | Dec 18, 2012 | Issued |
Array
(
[id] => 12016936
[patent_doc_number] => 09809629
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-07
[patent_title] => 'Hypoallergenic variants of Phl p 5, the major allergen from Phleum pratense'
[patent_app_type] => utility
[patent_app_number] => 14/366338
[patent_app_country] => US
[patent_app_date] => 2012-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 14
[patent_no_of_words] => 8483
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14366338
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/366338 | Hypoallergenic variants of Phl p 5, the major allergen from Phleum pratense | Dec 17, 2012 | Issued |
Array
(
[id] => 8883615
[patent_doc_number] => 20130156799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-20
[patent_title] => 'CONTIGUOUS OVERLAPPING PEPTIDES FOR TREATMENT OF BIRCH POLLEN ALLERGY'
[patent_app_type] => utility
[patent_app_number] => 13/718264
[patent_app_country] => US
[patent_app_date] => 2012-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7336
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13718264
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/718264 | CONTIGUOUS OVERLAPPING PEPTIDES FOR TREATMENT OF BIRCH POLLEN ALLERGY | Dec 17, 2012 | Abandoned |
Array
(
[id] => 8822428
[patent_doc_number] => 20130123473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-16
[patent_title] => 'BISPECIFIC ANTIBODY TARGETING A COMPLEMENT FACTOR OR COMPLEMENT REGULATORY PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 13/717230
[patent_app_country] => US
[patent_app_date] => 2012-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26562
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13717230
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/717230 | BISPECIFIC ANTIBODY TARGETING A COMPLEMENT FACTOR OR COMPLEMENT REGULATORY PROTEIN | Dec 16, 2012 | Abandoned |
Array
(
[id] => 11342394
[patent_doc_number] => 09526781
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-27
[patent_title] => 'Pharmaceutical formulations and the use thereof for the treatment of peanut allergy'
[patent_app_type] => utility
[patent_app_number] => 14/362588
[patent_app_country] => US
[patent_app_date] => 2012-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 4776
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14362588
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/362588 | Pharmaceutical formulations and the use thereof for the treatment of peanut allergy | Dec 13, 2012 | Issued |
Array
(
[id] => 8779544
[patent_doc_number] => 20130101519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'Diagnostic Method for Atherosclerosis'
[patent_app_type] => utility
[patent_app_number] => 13/714659
[patent_app_country] => US
[patent_app_date] => 2012-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8126
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13714659
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/714659 | Diagnostic method for atherosclerosis | Dec 13, 2012 | Issued |
Array
(
[id] => 9874721
[patent_doc_number] => 08961986
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-24
[patent_title] => 'Peptide composition'
[patent_app_type] => utility
[patent_app_number] => 13/706540
[patent_app_country] => US
[patent_app_date] => 2012-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 34
[patent_no_of_words] => 18349
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13706540
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/706540 | Peptide composition | Dec 5, 2012 | Issued |